Gemcitabine: Safety profile and efficacy in non-small cell lung cancer unaffected by age

Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas

Ephraim S. Casper, Mark R. Green, David P. Kelsen et al. · Investigational New Drugs · 1994 · 441 citations

Medicine, Oncology, Pharmacology +11

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.

Heather Anderson, Birthe Lund, Flemming W. Bach et al. · Journal of Clinical Oncology · 1994 · 376 citations

Medicine, Oncology, Pharmacology +15

Phase II study of gemcitabine in patients with advanced pancreatic cancer

J Carmichael, U. Fink, RC Russell et al. · British Journal of Cancer · 1996 · 370 citations · Full text

Medicine, Oncology, Pharmacology +11

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.

Raymond P. Abratt, W. R. Bezwoda, Geoffrey Falkson et al. · Journal of Clinical Oncology · 1994 · 361 citations

Medicine, Oncology, Pharmacotherapy +17

Phase II Study of Gemcitabine (2',2'-Difluorodeoxycytidine) in Previously Treated Ovarian Cancer Patients

Birthe Lund, Ole Hansen, Karen Theilade et al. · JNCI Journal of the National Cancer Institute · 1994 · 346 citations

Medicine, Oncology, Pharmacology +17